
what’s inside
Does a potential new blood pressure drug have negative effects on the nervous system? Which therapies show the most promise for treatment of Alzheimer’s disease? Are growing rates of neuropsychiatric disorders, such as Attention Deficit Hyperactivity Disorder (ADHD) and autism, linked to chemical exposure? How can we protect soldiers and civilians who are at risk from exposure to chemical weapons?
Neurobehavioral testing aims to answer these and other important questions. But all testing preclinical CROs are not created equal. How can you choose the right partner for your specific neuro-tox challenge?
Download Battelle's white paper - Detecting Neurobehavioral Effects: Considerations in the Design & Execution of Neurobehavioral Studies - to learn:
4 Primary Industries that Benefit from Neurobehavioral testing
6 critical considerations when selecting a preclinical CRO for testing
3 Tiers of Neurobehavioral Testing & What to know about each
Overview of neurobehavioral testing capabilities at Battelle